S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
How major US stock indexes fared Thursday, 4/18/2024
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
TSE:MBX

Microbix Biosystems (MBX) Stock Price, News & Analysis

C$0.36
+0.01 (+1.43%)
(As of 05:18 PM ET)
Today's Range
C$0.36
C$0.36
50-Day Range
C$0.35
C$0.43
52-Week Range
C$0.23
C$0.47
Volume
5,500 shs
Average Volume
72,244 shs
Market Capitalization
C$48.48 million
P/E Ratio
11.83
Dividend Yield
2.30%
Price Target
N/A
MBX stock logo

About Microbix Biosystems Stock (TSE:MBX)

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

MBX Stock Price History

MBX Stock News Headlines

Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Microbix’s Clot-Buster Drug Project Advances
Stocks in play: Microbix Biosystems Inc.
Microbix Biosystems Inc.
Microbix Announces Issuance of Stock Options
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Microbix Reports Record Results for Q1 Fiscal 2024
Microbix Schedules Release of Results for Q1 Fiscal 2024
Microbix Achieves Further QAPs Sales Record
Microbix Reports Results for Q4 & Full-Year Fiscal 2023
Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy
Microbix Presenting at Florida Capital Event Conference
Microbix QAPs Supporting HPV Testing in Ireland
Microbix Biosystems Inc. (MBX)
Microbix Achieves New QAPs Sales Record
See More Headlines
Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2024
Today
4/18/2024
Next Earnings (Estimated)
5/09/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$3.72 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$22.42 million
Cash Flow
C$0.08 per share
Book Value
C$0.20 per share

Miscellaneous

Free Float
N/A
Market Cap
C$47.79 million
Optionable
Not Optionable
Beta
0.28
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Cameron L. Groome
    President, CEO & Director
  • Mr. James S. Currie
    Chief Financial Officer
  • Dr. Kenneth Hughes Ph.D.
    Chief Operating Officer
  • Dr. Mark Luscher Ph.D.
    Senior Vice President of Scientific Affairs
  • Mr. Philip Casselli
    Senior Vice President of Sales, Business Development & Marketing
  • Mr. Christopher B. Lobb
    Compliance Officer, General Counsel & Secretary

MBX Stock Analysis - Frequently Asked Questions

Should I buy or sell Microbix Biosystems stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbix Biosystems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MBX shares.
View MBX analyst ratings
or view top-rated stocks.

How have MBX shares performed in 2024?

Microbix Biosystems' stock was trading at C$0.39 at the beginning of the year. Since then, MBX shares have decreased by 9.0% and is now trading at C$0.36.
View the best growth stocks for 2024 here
.

When is Microbix Biosystems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our MBX earnings forecast
.

How were Microbix Biosystems' earnings last quarter?

Microbix Biosystems Inc. (TSE:MBX) issued its quarterly earnings data on Wednesday, February, 14th. The company reported $0.02 EPS for the quarter. The business had revenue of $8.41 million for the quarter, compared to analyst estimates of $8.10 million. Microbix Biosystems had a net margin of 16.57% and a trailing twelve-month return on equity of 14.66%.

What other stocks do shareholders of Microbix Biosystems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), Organigram (OGI), Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), BlackBerry (BB) and Canadian Western Bank (CWB).

How do I buy shares of Microbix Biosystems?

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:MBX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners